AN ACT relating to undesignated glucagon.

Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school; permit authorized entities to receive, possess, and administer undesignated glucagon to a student during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good-faith actions to use undesignated glucagon to treat diabetic medical emergencies; require the Cabinet for Health and Family Services to consult the American Diabetes Association when promulgating administrative regulations related to the administration of undesignated glucagon in schools.